Eiichi Sato

16.4k total citations · 3 hit papers
262 papers, 11.1k citations indexed

About

Eiichi Sato is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Eiichi Sato has authored 262 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Immunology, 71 papers in Oncology and 69 papers in Surgery. Recurrent topics in Eiichi Sato's work include Glycosylation and Glycoproteins Research (38 papers), Immunotherapy and Immune Responses (33 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Eiichi Sato is often cited by papers focused on Glycosylation and Glycoproteins Research (38 papers), Immunotherapy and Immune Responses (33 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Eiichi Sato collaborates with scholars based in Japan, United States and Australia. Eiichi Sato's co-authors include Suguru Yonezawa, Hiroyoshi Nishikawa, Lloyd J. Old, Haruo Ohtani, Sacha Gnjatic, Achim A. Jungbluth, Gerd Ritter, Sadao Tanaka, Denise Frosina and Shimon Sakaguchi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Eiichi Sato

255 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraepithelial CD8⁺tumor-infiltrating lymphocytes and a high CD8⁺/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

2005 1.9k citations Eiichi Sato, Hiroyoshi Nishikawa et al. profile →
PD-1 ⁺ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

2019 692 citations Eiichi Sato, Shimon Sakaguchi et al. profile →
Anti-CCR4 mAb selectively depletes effector-type FoxP3⁺CD4⁺regulatory T cells, evoking antitumor immune responses in humans

2013 505 citations Hiroyoshi Nishikawa, Yuka Maeda et al. profile →

Peers

Countries citing papers authored by Eiichi Sato

Since Specialization

Citations

This map shows the geographic impact of Eiichi Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Sato more than expected).

Fields of papers citing papers by Eiichi Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Sato. The network helps show where Eiichi Sato may publish in the future.

Co-authorship network of co-authors of Eiichi Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Sato. A scholar is included among the top collaborators of Eiichi Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Sato. Eiichi Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors 2023 ·British Journal of Cancer ·Yoshinori Hayashi, Tomoki Makino, Eiichi Sato, Kenji Ohshima, (unknown), Takashi Kanemura, Keiichiro Honma, Kotaro Yamashita, Takuro Saito, Koji Tanaka, Kazuyoshi Yamamoto, Tsuyoshi Takahashi, Yukinori Kurokawa, Hiroshi Miyata, Kiyokazu Nakajima, Hisashi Wada, Eiichi Morii, Hidetoshi Eguchi, Yuichiro� Doki	55
2	First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors 2020 ·Cancer Immunology Immunotherapy ·Mikiya Ishihara, (unknown), Yoshihiro Miyahara, Daisuke Muraoka, Naozumi Harada, Shinichi Kageyama, Takeshi Sasaki, (unknown), Norihito Soga, Katsunori Uchida, Taizo Shiraishi, Eiichi Sato, Hideki Kanda, Toshiro Mizuno, Gill Webster, Hiroaki Ikeda, Naoyuki Katayama, Yoshiki Sugimura, Hiroshi Shiku	21
3	HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer 2018 ·International Journal of Molecular Sciences ·Mari Hosonaga, Yoshimi Arima, Oltea Sampetrean, Daisuke Komura, Ikuko Koya, Takashi Sasaki, Eiichi Sato, Hideyuki Okano, Jun Kudoh, Shumpei Ishikawa, Hideyuki Saya, Takashi Ishikawa	26
4	LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: A retrospective analysis 2014 ·Diabetes Research and Clinical Practice ·Eiichi Sato, Mayuko Amaha, Mayumi Nomura, Daisuke Matsumura, Yoshihiko Ueda, Tsukasa Nakamura	6
5	Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760) 2014 ·Journal of Thoracic Oncology ·Koji Kurose, Yoshihiro Ohue, Eiichi Sato, Akira Yamauchi, Shingo Eikawa, Midori Isobe, (unknown), Akiko Uenaka, Mikio Oka, Eiichi Nakayama	48
6	Significance of Akt activation and AKT gene increases in soft tissue tumors 2013 ·Human Pathology ·Yoh Dobashi, Eiichi Sato, Yoshinao Oda, Johji Inazawa, Akishi Ooi	9
7	Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy 2012 ·Cancer Research ·Takuro Noguchi, Takuma Kato, Linan Wang, Yuka Maeda, Hiroaki Ikeda, Eiichi Sato, Alexander Knuth, Sacha Gnjatic, Gerd Ritter, Shimon Sakaguchi, Lloyd J. Old, Hiroshi Shiku, Hiroyoshi Nishikawa	43
8	Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals 2010 ·Clinical Cancer Research ·(unknown), Hiroyoshi Nishikawa, Daisuke Muraoka, Linan Wang, Takuro Noguchi, Eiichi Sato, Satoshi Kondo, James P. Allison, Shimon Sakaguchi, Lloyd J. Old, Takuma Kato, Hiroshi Shiku	106
9	Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432 2009 ·Vaccine ·Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, Shigehisa Kitano, (unknown), Hiroaki Ikeda, Hideki Toyoda, Kyosuke Tanaka, Michiyuki Kanai, Arimichi Takabayashi, Hiroshi Imai, Taizo Shiraishi, Eiichi Sato, Hisashi Wada, Eiichi Nakayama, Yoshiyuki Takei, Naoyuki Katayama, Hiroshi Shiku, Shinichi Kageyama	43
10	Regulatory T Cell–Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling 2008 ·Cancer Research ·Hiroyoshi Nishikawa, Takuma Kato, (unknown), Yuki Orito, Eiichi Sato, Naozumi Harada, Sacha Gnjatic, Lloyd J. Old, Hiroshi Shiku	66
11	Abnormality of Retinal Arterial Circulation in a Case of Takayasu Arteritis with Aortic Regurgitation 2007 ·Atsushi Takahashi, Taiji Nagaoka, Eiichi Sato, Akitoshi Yoshida	1
12	Prediction of ambulation prognosis in the elderly after hip fracture 2006 ·International Orthopaedics ·Tetsuo Hagino, Eiichi Sato, (unknown), Satoshi Ochiai, (unknown), Yoshiki Hamada	32
13	Infiltrating CD8+ T Cells in Oral Lichen Planus Predominantly Express CCR5 and CXCR3 and Carry Respective Chemokine Ligands RANTES/CCL5 and IP-10/CXCL10 in Their Cytolytic Granules 2003 ·American Journal Of Pathology ·(unknown), Haruo Ohtani, Takashi Nakayama, Yumiko Sugawara, Eiichi Sato, Hiroshi Nagura, Osamu Yoshie, Takashi Sasano	122
14	Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan 2001 ·Cancer Letters ·Aihua Li, Suguru Yonezawa, Sumika Matsukita, Kazuhisa Hasui, Masamichi Goto, Sadao Tanaka, (unknown), Eiichi Sato	5
15	Kudo Total Elbow Arthroplasty in Patients with Rheumatoid Arthritis 2001 ·Journal of Bone and Joint Surgery ·Nobuyuki Tanaka, Hiroshi Kudo, K Iwano, Hisashi Sakahashi, Eiichi Sato, Seiichi Ishii	58
16	Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: Its relationship with prognosis 1999 ·International Journal of Cancer ·(unknown), Suguru Yonezawa, Koji Nagata, (unknown), Shoji Natsugoe, Pei‐Xiang Xing, Ian F. C. McKenzie, Takashi Aikou, Eiichi Sato	53
17	Expression of Mucin Carbohydrates and Core Proteins in Carcinomas of the Ampulla of Vater: Their Relationship to Prognosis 1996 ·Japanese Journal of Cancer Research ·Hiroshi Kitamura, Suguru Yonezawa, Sadao Tanaka, Young S. Kim, Eiichi Sato	60
18	A Case of Epidermotrophic Ki-1 Positive Large Anaplastic Cell Lymphoma possibly Occurred in Solitary Type Pagetoid Rericulosis 1996 ·Kyoko Kawamura, Kazuhisa Hasui, Eiichi Sato, (unknown), (unknown), (unknown), Tamotsu Kanzaki	1
19	Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV-I-Associated Myelopathy 1993 ·Journal of Neuropathology & Experimental Neurology ·Fujio Umehara, Shuji Izumo, Masanori Nakagawa, (unknown), Kouichi Takahashi, Kenji Matsumuro, Eiichi Sato, Mitsuhiro Osame	176
20	An electronmicroscopic cytomorphometric analysis of 55 cases of T-cell lymphomas. 1989 ·Kazuhisa Hasui, Eiichi Sato, (unknown), Shinichi Kitajima, Masamichi Goto, Masayoshi Tokunaga	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact